Skip to main content

Table 1 General characteristics of patients with compensated liver cirrhosis

From: Correlation between serum liver fibrosis markers and early gastroesophageal varices among patients with compensated liver cirrhosis: a cross-sectional analysis

Variables

n = 791

Age (years)

52 (42,59)

Male, n(%)

468 (59.2%)

Aetiology of cirrhosis, n(%)

 HBV

561 (71%)

 HCV

111 (14%)

 others

119 (15%)

Child category, n(%)

 A

716 (90.5%)

 B

75 (9.5%)

 ALT(U/L)

51 (26, 123)

 AST(U/L)

46 (27, 103)

 TBIL (umol/L)

17.4 (13.2, 24.4)

 ALB(g/L)

42.6 (38.8, 45.9)

 PLT(× 109/L)

136 (99, 173.5)

 PT(s)

13.6 (12.8, 14.6)

 Hyaluronic acid (ng/ml)

148 (93, 332)

 Laminin (ng/ml)

96 (86, 129)

 type III pro-collagen (ng/ml)

9.8 (7, 14)

 Collagen type IV (ng/ml)

78 (63, 154)

 LS (kPa)

15.1 (9, 25.7)

 Splenic diameter (mm)

114 (102, 126)

 APRI

1 (0.5, 2.4)

 FIB-4

2.73 (1.56, 5.05)

  1. Data are expressed as median (quartile 25, quartile 75) or number (proportion)
  2. ALT alanine aminotransferase, AST aspartate aminotransferase, TBIL total bilirubin, ALB albumin, PLT platelet, PT prothrombin time, LS liver stiffness, APRI: Aspartate aminotransferase-to-Platelet Ratio Index, FIB-4: Fibrosis 4 Score